![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 29673 |
FusionGeneSummary for PUM2_ATF5 |
![]() |
Fusion gene information | Fusion gene name: PUM2_ATF5 | Fusion gene ID: 29673 | Hgene | Tgene | Gene symbol | PUM2 | ATF5 | Gene ID | 23369 | 22809 |
Gene name | pumilio RNA binding family member 2 | activating transcription factor 5 | |
Synonyms | PUMH2|PUML2 | ATFX|HMFN0395 | |
Cytomap | 2p24.1 | 19q13.33 | |
Type of gene | protein-coding | protein-coding | |
Description | pumilio homolog 2pumilio-2 | cyclic AMP-dependent transcription factor ATF-5cAMP-dependent transcription factor ATF-5transcription factor ATFx | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | Q8TB72 | Q9Y2D1 | |
Ensembl transtripts involved in fusion gene | ENST00000338086, ENST00000319801, ENST00000361078, ENST00000536417, ENST00000403432, ENST00000420234, | ENST00000595125, ENST00000423777, ENST00000600336, | |
Fusion gene scores | * DoF score | 12 X 11 X 8=1056 | 5 X 5 X 2=50 |
# samples | 13 | 5 | |
** MAII score | log2(13/1056*10)=-3.02202630633 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/50*10)=0 | |
Context | PubMed: PUM2 [Title/Abstract] AND ATF5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PUM2 | GO:0010608 | posttranscriptional regulation of gene expression | 25100735 |
Hgene | PUM2 | GO:0043488 | regulation of mRNA stability | 26724866 |
Hgene | PUM2 | GO:0051983 | regulation of chromosome segregation | 26724866 |
Hgene | PUM2 | GO:1900246 | positive regulation of RIG-I signaling pathway | 25340845 |
Tgene | ATF5 | GO:0006355 | regulation of transcription, DNA-templated | 20654631 |
Tgene | ATF5 | GO:0008285 | negative regulation of cell proliferation | 22528486 |
Tgene | ATF5 | GO:0045892 | negative regulation of transcription, DNA-templated | 22528486 |
Tgene | ATF5 | GO:0045893 | positive regulation of transcription, DNA-templated | 21212266|25512613 |
Tgene | ATF5 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 16300731 |
Tgene | ATF5 | GO:0046605 | regulation of centrosome cycle | 26213385 |
Tgene | ATF5 | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 22528486 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BE708509 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000338086 | ENST00000595125 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-3UTR | ENST00000338086 | ENST00000423777 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000338086 | ENST00000600336 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000319801 | ENST00000595125 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-3UTR | ENST00000319801 | ENST00000423777 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000319801 | ENST00000600336 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000361078 | ENST00000595125 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-3UTR | ENST00000361078 | ENST00000423777 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000361078 | ENST00000600336 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000536417 | ENST00000595125 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-3UTR | ENST00000536417 | ENST00000423777 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000536417 | ENST00000600336 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000403432 | ENST00000595125 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-3UTR | ENST00000403432 | ENST00000423777 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000403432 | ENST00000600336 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000420234 | ENST00000595125 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-3UTR | ENST00000420234 | ENST00000423777 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
intron-intron | ENST00000420234 | ENST00000600336 | PUM2 | chr2 | 20450480 | - | ATF5 | chr19 | 50436873 | + |
Top |
FusionProtFeatures for PUM2_ATF5 |
![]() |
Hgene | Tgene |
PUM2 | ATF5 |
Sequence-specific RNA-binding protein that acts as apost-transcriptional repressor by binding the 3'-UTR of mRNAtargets. Binds to an RNA consensus sequence, the Pumilio ResponseElement (PRE), 5'-UGUANAUA-3', that is related to the NanosResponse Element (NRE) (, PubMed:21397187). Mediates post-transcriptional repression of transcripts via differentmechanisms: acts via direct recruitment of the CCR4-POP2-NOTdeadenylase leading to translational inhibition and mRNAdegradation (PubMed:22955276). Also mediates deadenylation-independent repression by promoting accessibility of miRNAs(PubMed:18776931, PubMed:22345517). Acts as a post-transcriptionalrepressor of E2F3 mRNAs by binding to its 3'-UTR and facilitatingmiRNA regulation (PubMed:22345517). Plays a role in cytoplasmicsensing of viral infection (PubMed:25340845). Represses a programof genes necessary to maintain genomic stability such as keymitotic, DNA repair and DNA replication factors. Its ability torepress those target mRNAs is regulated by the lncRNA NORAD (non-coding RNA activated by DNA damage) which, due to its highabundance and multitude of PUMILIO binding sites, is able tosequester a significant fraction of PUM1 and PUM2 in the cytoplasm(PubMed:26724866). May regulate DCUN1D3 mRNA levels(PubMed:25349211). May support proliferation and self-renewal ofstem cells. Binds specifically to miRNA MIR199A precursor, withPUM1, regulates miRNA MIR199A expression at a postranscriptionallevel (PubMed:28431233). {ECO:0000269|PubMed:18776931,ECO:0000269|PubMed:21397187, ECO:0000269|PubMed:22345517,ECO:0000269|PubMed:22955276, ECO:0000269|PubMed:25340845,ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:26724866,ECO:0000269|PubMed:28431233}. | Transcription factor that either stimulates or repressesgene transcription through binding of different DNA regulatoryelements such as cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), ATF5-specific response element (ARE)(consensus: 5'-C[CT]TCT[CT]CCTT[AT]-3') but also the amino acidresponse element (AARE), present in many viral and cellularpromoters. Critically involved, often in a cell type-dependentmanner, in cell survival, proliferation, and differentiation(PubMed:10373550, PubMed:15358120, PubMed:21212266,PubMed:20654631). Its transcriptional activity is enhanced byCCND3 and slightly inhibited by CDK4 (PubMed:15358120). Importantregulator of the cerebral cortex formation, functions in cerebralcortical neuroprogenitor cells to maintain proliferation and toblock differentiation into neurons. Must be down-regulated inorder for such cells to exit the cycle and differentiate (Bysimilarity). Participates in the pathways by which SHH promotescerebellar granule neuron progenitor cells proliferation (Bysimilarity). Critical for survival of mature olfactory sensoryneurons (OSN), directs expression of OSN-specific genes (Bysimilarity). May be involved in osteogenic differentiation(PubMed:22442021). Promotes cell proliferation and survival byinducing the expression of EGR1 sinergistically with ELK1. Onceacetylated by EP300, binds to ARE sequences on target genespromoters, such as BCL2 and EGR1 (PubMed:21791614). Plays an anti-apoptotic role through the transcriptional regulation of BCL2,this function seems to be cell type-dependent (By similarity).Cooperates with NR1I3/CAR in the transcriptional activation ofCYP2B6 in liver (PubMed:18332083). In hepatic cells, repressesCRE-dependent transcription and inhibits proliferation by blockingat G2/M phase (PubMed:22528486, PubMed:18701499). May act as anegative regulator of IL1B transduction pathway in liver(PubMed:24379400). Upon IL1B stimulus, cooperates with NLK toactivate the transactivation activity of C/EBP subfamily members(PubMed:25512613). Besides its function of transcription factor,acts as a cofactor of CEBPB to activate CEBPA and promoteadipocyte differentiation (PubMed:24216764). Regulates centrosomedynamics in a cell-cycle- and centriole-age-dependent manner.Forms 9-foci symmetrical ring scaffold around the mother centrioleto control centrosome function and the interaction betweencentrioles and pericentriolar material (PubMed:26213385).{ECO:0000250|UniProtKB:O70191, ECO:0000250|UniProtKB:Q6P788,ECO:0000269|PubMed:10373550, ECO:0000269|PubMed:15358120,ECO:0000269|PubMed:18332083, ECO:0000269|PubMed:18701499,ECO:0000269|PubMed:20654631, ECO:0000269|PubMed:21212266,ECO:0000269|PubMed:21791614, ECO:0000269|PubMed:22442021,ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:24216764,ECO:0000269|PubMed:24379400, ECO:0000269|PubMed:25512613,ECO:0000269|PubMed:26213385}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PUM2_ATF5 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PUM2_ATF5 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PUM2_ATF5 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PUM2_ATF5 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ATF5 | C0005586 | Bipolar Disorder | 1 | PSYGENET |